Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-25 @ 3:44 AM
NCT ID:
NCT04024202
Eligibility Criteria:
Inclusion Criteria:
* Sufficient comprehension of the Dutch language
* Signed informed consent by patient and/or parent/caretaker or donor
* Patients older than 3 months
* Patients with a positive DAT, a positive eluate and signs of hemolysis\*
* Patients with a positive DAT with complement only, negative eluate, but with signs of hemolysis
* Donors with a (repeatedly) positive DAT and a positive eluate and/or clinically relevant cold auto-antibodies
Exclusion Criteria:
* Prior inclusion in the DRAIHA study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
3 Months
Study:
NCT04024202
Study Brief:
Protocol Section:
NCT04024202